MBE Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,424
Closed -$274K 61
2022
Q2
$274K Sell
5,424
-594
-10% -$32.4K 0.19% 51
2022
Q1
$367K Sell
6,018
-696
-10% -$41.5K 0.22% 39
2021
Q4
$442K Sell
6,714
-1,009
-13% -$64.6K 0.23% 33
2021
Q3
$485K Sell
7,723
-1,691
-18% -$108K 0.25% 28
2021
Q2
$567K Sell
9,414
-70,890
-88% -$4.1M 0.29% 23
2021
Q1
$4.42M Sell
80,304
-2,328
-3% -$129K 2.4% 13
2020
Q4
$4.51M Buy
82,632
+5,430
+7% +$284K 3.05% 11
2020
Q3
$3.41M Buy
77,202
+150
+0.2% +$7.26K 2.86% 11
2020
Q2
$3.4M Buy
77,052
+76,980
+106,917% +$3.29M 2.86% 11
2020
Q1
$2K Buy
+72
New +$3.03K ﹤0.01% 454

Other funds holding IHI

MBE Wealth Management's IHI Position: Q3 2022 in Review

MBE Wealth Management sold out of iShares US Medical Devices ETF (IHI) in Q3 2022, closing a stake of 5,424 shares — an estimated $274K sold.

MBE Wealth Management first reported a position in IHI in Q1 2020 and held it in 10 quarters. The position peaked at $4.51M in Q4 2020. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

  • MBE Wealth Management reported no remaining iShares US Medical Devices ETF position as of Q3 2022 after selling out during the quarter.
  • MBE Wealth Management sold 5,424 iShares US Medical Devices ETF shares in Q3 2022, an estimated $274K.
  • MBE Wealth Management first reported a position in iShares US Medical Devices ETF in Q1 2020 and held it in 10 quarters.
  • MBE Wealth Management's iShares US Medical Devices ETF position peaked at $4.51M in Q4 2020.
  • 556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on MBE Wealth Management's 13F filing for Q3 2022, filed 20 Oct 2022.